Controversial study claims this simple brain exercise can cut dementia risk by 25% Further research is still needed to prove effects of such exercise, scientists say The Independent UK · Feb 10
Researchers investigating if drugs can be repurposed to combat dementia Developing new medications for diseases like Alzheimer’s can be very expensive, and take a long time. The Independent UK · Oct 17, 2024
Alzheimer’s breakthrough as blood tests could be offered on NHS Dementia affects around 900,000 people in the UK and experts predict that will rise to 1.4 million people by 2040 The Independent UK · Nov 9, 2023
Blood tests for Alzheimer’s could be offered on NHS within five years – experts Less than two-thirds of people in England with dementia have a formal diagnosis. The Independent UK · Nov 9, 2023
New drug found to slow Alzheimer’s hailed as turning point Donanemab has been found to slow down the disease in a clinical trial. The Independent UK · Jul 17, 2023
Everything we know about breakthrough Alzheimer’s drug Donanemab Alzheimer’s disease is the most common cause of dementia in the UK The Independent UK · Jul 17, 2023
Alzheimer’s: ‘Turning point’ in fight against disease as drug found to slow decline by up to 35% Experts say ‘we’re entering a new era where Alzheimer’s disease could become treatable’ Evening Standard · Jul 17, 2023
Experts urge health regulators to approve ‘turning point’ dementia drugs Exclusive: As results show 35% slowing in cognitive decline, health leaders say swift decisions crucial The Guardian - UK · Jul 17, 2023
Hope for Alzheimer's patients as doctors develop drug to slow effect of illness Experts said 'this could be the beginning of the end' of the disease after donanemab slowed brain decline by 36% in a late-stage clinical trial Daily Mirror · May 3, 2023
Three or more concussions linked to worsened brain function in later life The data comes from the PROTECT study. The Independent UK · Jan 31, 2023
Alzheimer's disease could be slowed down by new drug as NHS urged to speed up testing Lecanemab could mark 'the end of the beginning' in the decades-long fight against dementia, geneticist Prof Sir John Hardy said. The drug was found to reduce brain decline in those with mild dementia Daily Mirror · Nov 23, 2022
Breakthrough Alzheimer’s drug could be in UK use in a year but only for minority Only 5% of patients eligible for the drug will be able to access it – and most of these will be private cases, experts have said. The Independent UK · Nov 23, 2022
Rugby authorities urged to cut out contact training to reduce the risk of motor neurone disease New research has found evidence of an increased risk of motor neurone disease among former rugby players The Independent UK · Oct 5, 2022
Rugby chiefs urged to end contact training to reduce motor neurone disease risk A study led by the University of Glasgow looked at former Scotland internationals. The Independent UK · Oct 5, 2022
The Independent UK · Oct 5, 2022 Rugby players 15 times more likely to develop motor neurone disease, new research finds Research led by the University of Glasgow found evidence of an increased risk of motor neurone disease among former rugby players
The Independent UK · Oct 4, 2022 Rugby authorities urged to cut out contact training to reduce the risk of MND Research led by the University of Glasgow found evidence of an increased risk of motor neurone disease among former rugby players.
Daily Mirror · Sep 30, 2022 5 bits of good news you might have missed this week - including Alzheimer's breakthrough The news has been pretty bleak lately and it's been hard to keep up with all the sombre events that have been going on, so you may have missed a few stories that could make you a bit more hopeful for the future
Daily Mirror · Sep 28, 2022 First ever drug to treat Alzheimer's disease could be available to Brits in two years The Lecanemab drug has been shown to reduce the decline in memory and thinking skills by 27% over 18 months in those with early-stage Alzheimer's - making it the only medication to treat the underlying disease
Daily Mirror · Sep 28, 2022 World's first EVER drug shown to work against Alzheimer's developed by scientists Scientists say the development of the only drug to work against Alzheimer’s is a 'historic moment' - with regulators expected to approve the groundbreaking drug by the New Year
The Independent UK · Sep 28, 2022 ‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’ The new clinical trial found that there was a significant reduction in the decline in memory and thinking usually seen in early-stage patients.